SHARON POWERS: Open Payments
NPI 1447691456 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 77 payments from 20 companies in 2025. Trend: 2023 $1,032 · 2024 $1,729 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $334 |
| Amgen Inc. | 13 | $201 |
| AstraZeneca Pharmaceuticals LP | 9 | $200 |
| ABBVIE INC. | 7 | $166 |
| PFIZER INC. | 5 | $115 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Corium, LLC | 3 | $76 |
| Exact Sciences Corporation | 4 | $71 |
| Abbott Laboratories | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
Products named: Ozempic, OTEZLA, Wegovy, NURTEC ODT, BREZTRI, TRELEGY ELLIPTA, Azstarys, UBRELVY.
Industry payments across FL — which companies pay providers there.
